When there is no deviation of the concentration from the range of values steroids normally found in humans and as a result of any reliable analytical method (e.g. IRMS), is not set exogenous origin substance, but there is reason to believe, for example based on a comparison of endogenous steroid profiles that may, involved the use of banned substances, or when the laboratory reports testosterone epitestosterone ratio to more than 4 to 1, and any reliable method (e.g. IMRS) not determined be exogenous origin of the substance, the relevant Anti-Doping Organization shall conduct a further investigation by reviewing the results of any previous tests or by conducting subsequent test.
When such further investigation is required, the results reported by the laboratory as an atypical and not as adverse. If as a result of additional reliable method (e.g. IRMS) laboratory reports that the prohibited substance is of exogenous origin, there is no need for further investigation, and the sample is deemed to contain a prohibited substance. Unless an additional reliable method for the analysis (e.g. IRMS), and the results have at least three previous tests, it is determined longitudinal profile athlete for a long time by appropriate doping organization without notice three tests in a three month period.
The results, which led to the study of steroid profile for a long time, reported as atypical. If during the longitudinal profile of the athlete, determined by the subsequent tests is not physiologically normal, the reported unfavorable result of the analysis. In extremely rare individual cases in urine in very low concentrations of a few nanograms per milliliter (ng / ml) can be detected systematically boldenone endogenous origin. If the laboratory has reported a very low concentration of boldenone, and the use of reliable methods for analyzing (e.g. IRMS) not determined the exogenous origin of the substance can be conducted further investigation based on subsequent tests.
Mention reported by a laboratory Adverse Analytical Finding this substance as norandrosterone-19 is considered to be scientific and valid proof of exogenous origin of a Prohibited Substance. In this case, there is no need to conduct further investigation.
Should an Athlete fail to cooperate in the investigations, the Athlete’s Sample shall be deemed to contain a prohibited substance.
S1.2. Other anabolic agents (list not exhaustive) Clenbuterol, selective androgen receptor modulators (SARMs), tibolone, zeranol, zilpaterol.
In this section:
* “exogenous” refers to a substance that can not be produced by the body;
** “endogenous” refers to a substance that can be produced or–organisms.
HORMONES AND RELATED SUBSTANCES
The following substances and their releasing factors:
1. Erythropoietin (EPO);
2. growth hormone (hGH), insulin-like growth factors (e.g. IGF-1), Mechano Growth Factors (IRF);
3. gonadotropin (e.g. LH, hCG) – prohibited in males only;
and other substances with similar chemical structure with or similar biological effects.
If the athlete does not demonstrate that the concentration due to a physiological or pathological condition, the sample is deemed to contain any of the prohibited substances listed in the above list, when the concentration of the forbidden substance or its metabolites or markers and / or their corresponding relations in the sample Athlete exceed the range of values normally found in humans, and is unlikely to be consistent with normal endogenous production.
If the application of a reliable method of laboratory reports that the prohibited substance is of exogenous origin, the sample is deemed to contain a forbidden substance and will be reported on the adverse result of the analysis.
All beta-2 agonists including their D- and L-isomers.
An exception, formoterol, salbutamol, salmeterol and terbutaline, when administered by inhalation; this requires permit a therapeutic use for a simplified procedure.
Regardless of whether the athlete a therapeutic use has received, the concentration of salbutamol (free plus glucuronide) greater than 1000 ng / ml would be considered unfavorable result of analysis, except for those cases when an athlete is able to prove that this result is a consequence of the therapeutic use of inhaled salbutamol.
HORMONE ANTAGONISTS AND MODULATORS
The following classes:
1. Aromatase inhibitors including anastrozole, letrozole, aminoglutethimide, exemestane, formestane, testolactone, etc.;
2. Selective estrogen receptor modulators (SERMs), including raloxifene, tamoxifen, toremifene, etc.;
3. Other anti-estrogenic substances including clomiphene, cyclofenil, fulvestrant.
4. Agents modifying myostatin function, including myostatin inhibitors, and others.
DIURETICS AND OTHER MASKING AGENTS
Masking agents are prohibited. These include:
diuretics *, epitestosterone, probenecid, alpha-reductase inhibitors (e.g., finasteride, dutasteride), plasma substitutes (e.g., albumin, dextran, hydroxyethyl starch) and other substances with similar biological effects. diuretics:
acetazolamide, amiloride, bumetanide, canrenone, chlorthalidone, эtakrinicheskaya Chisloth, furosemide, indapamide, metolazone, spironolactone, tiazidы (e.g. bendroflyumetiazid, chlorothiazide, gidrohlorotiazid), triamterene, and takzhe Tablets substances omega shozhey himicheskoy textured or shozhimi biologicheskimi эffektami (for isklyucheniem drosperinone, no liens). * Permission to terapevticheskoe ispolyzovanie zapreshtennыh substantsiy not deystvuet, Esslin in Moche sportsman soderzhitsya diuretic naryadu with porogovыm or subporogovыm urovnem zapreshtennoy substances.
CHEMICAL AND PHYSICAL MANIPULATION
1. Tampering, or attempting to tamper, in order to alter the integrity and validity of Samples collected in Doping Controls. It may include, e.g., catheterization, substitution and / or alteration of urine. 2. Intravenous infusions are prohibited. In the case of an acute medical situation where the use of this method is deemed necessary, require retroactive authorization for therapeutic use.
Ministry of Health. GENE DOPING
The non-therapeutic use of cells, genes, genetic elements, or modulation of gene expression that can improve sports result.
SUBSTANCES AND METHODS PROHIBITED IN-COMPETITION
In addition to the categories listed in sections S1-S5 and M1 to M3 defined above, the following categories are prohibited competition:
All stimulants, including both their optical (D- and L-), except imidazole derivatives for topical use and those stimulants included in the 2008 Monitoring Program *. Stimulants include:
Stimulants include: adrafinil, adrenaline **, amfepramone, amiphenazole, amphetamine, amphetamine, benzphetamine, benzalpiperazin, bromantan, cathine ***, clobenzorex, cocaine, cropropamide, crotetamide, tsiklazodon, dimethylamphetamine, ephedrine ****, etamivan, etilamphetamine, etilefrin, famprofazone, fenbutrazate, fencamfamin, fencamine, fenetylline, fenfluramine, fenproporex, furfenorex, heptaminol, isometheptene, levmethamfetamine, meclofenoxate, mefenorex, mephentermine, mesocarb, methamphetamine (D-), methylenedioxyamphetamine, methylenedioxymethamphetamine, p-methyl etamin, methylephedrine ***, methylphenidate, modafinil, nikethamide, norfepefrin, norfenfluramine, octopamine, ortetamin, oksilofrin, parahydroxyamphetamine, pemoline, pentetrazole, phendimetrazine, phenmetrazine, fenprometamin, phentermine, fenilpiratsetam 4- (Carphedon), prolintane, propylhexedrine, selegiline, sibutramine, strychnine, tuaminoheptane and other substances with similar chemical structure or similar biological effects. * The following substances included in the 2008 Monitoring Program (bupropion, caffeine, phenylephrine, phenylpropanolamine, pipradol, pseudoephedrine, synephrine) are not considered as Prohibited Substances.
** Adrenaline associated with local anesthetic agents or by local administration (eg nasal, ophthalmologic) is not prohibited. *** Katin is prohibited when its concentration in urine greater than 5 micrograms per milliliter. **** ephedrine and methylephedrine is prohibited when its concentration of each of them in the urine exceeds 10 micrograms per milliliter.
Stimulant, is not directly referred to in this section as an example, it is considered to be a special substance only if it is established that the use of this substance athlete may be considered as inadvertent doping violation because of its general availability in medicinal products or in view of the ambiguity of its ability to influence sports results.
SUBSTANCES PROHIBITED IN PARTICULAR SPORTS
Alcohol (ethanol) is prohibited in-competition only, in the following sports. It is detected by breath analysis and / or blood. Threshold (haematological values), above which is a violation of anti-doping rules, specified for each in parentheses federation.
• Aeronautics (FAI) (0,20 g / L)
• archery (FITA, IPC) (0,10 g / L)
• Auto Racing (FIA) (0,10 grams / liter)
• Petank (IPC) (0,10 g / L)
• Karate (WKF) (0,10 g / L)
• Modern Pentathlon (UIPM)
for disciplines involving shooting (0.10 g / L)
• Motorcycling (FIA) (0.10 g / l)
• Powerboating (UIM) (0,30 g / l)
Unless otherwise specified, beta-blockers are prohibited in-competition only, in the following sports:
• Aeronautics (the FAI)
• Archery (FITA, IPC) (also prohibited out of competition)
• Auto Racing (the FIA)
• Pool Fitness ( WCBS)
• Bobsleigh (FIBT)
• boules (CMSV, IPC)
• Bridge (FMB)
• Curling (WCF)
• Gymnastics (FIG)
• Motorcycling (FIM)
• Modern Pentathlon (UIPM) for disciplines involving shooting
• Bowling (the FIQ)
• Powerboating (the UIM)
• Sailing (ISAF) (only mat match race helms)
• Shooting (ISSF, IPC) (also prohibited out of competition)
• Skiing / snowboarding (the FIS) (ski jumping, jumping (freestyle) / halfpipe and snowboard halfpipe / big air)
• Wrestling (the FILA)
beta-blockers include (list is not exhaustive):
acebutolol, alprenolol, atenolol, betaxolol, bisoprolol, bunolol, carteolol, carvedilol, celiprolol, esmolol, labetalol, levobunolol, metipranolo l, metoprolol, nadolol, oxprenolol, pindolol, propranolol, sotalol, timolol.
SPECIFIED SUBSTANCES *
“Specified Substances” * are listed below:
• all beta-2 agonists by inhalation, except salbutamol (free plus glucuronide) greater than 1000 ng / mL and clenbuterol (listed in section S 1.2: Other anabolic agents);
• alpha-reductase inhibitors, probenecid;
• cathine, cropropamide, crotetamide, ephedrine, etamivan, famprofazone, heptaminol, isometheptene, levmetanfetamin, meclofenoxate, p-methylamphetamine, metalefedrin, niketamid, norfenefrine, octopamine, ortetamin, oksilofrin, fenprometamin, propylhexedrine, selegiline, sibutramine, tuaminoheptane and any other stimulant which are not specifically listed in S6 section and on which it found that the condition of the athlete corresponds to the conditions described in section S6;
• All glucocorticosteroids;
• All beta-blockers.
* “The Prohibited List may be designated a special substance, the use of which may be regarded as unintentional, because of their general availability or because of the ambiguity of their ability to influence sports results.” Doping rule violation as a result of the use of these substances can be reduced sanction if it is determined that “an athlete has used this substance was not intended to enhance sport performance.”